Ipsen

Ipsen is a global biopharmaceutical group dedicated to developing and commercializing innovative medicines in specialty care areas such as oncology, neurology, and rare diseases. While not explicitly named in the provided snippets, Ipsen is a significant player within the European pharmaceutical landscape, which is currently facing challenges. Recent news indicates that major European drugmakers, including French companies, are expressing concerns about losing ground to US and Chinese rivals in drug development and investment. This sentiment has led to the formation of new lobbying groups, like "Initiative Pharma" by seven major French laboratories, aimed at defending "sanitary sovereignty." These developments highlight a broader industry trend where European pharmaceutical companies are seeking to bolster their competitiveness and influence in the global market, emphasizing the need for strategic action to safeguard their position and innovation capabilities.